NO994083D0 - Selektiv epoksideringsmetode for fremstilling av farmasöytiske forbindelser - Google Patents
Selektiv epoksideringsmetode for fremstilling av farmasöytiske forbindelserInfo
- Publication number
- NO994083D0 NO994083D0 NO994083A NO994083A NO994083D0 NO 994083 D0 NO994083 D0 NO 994083D0 NO 994083 A NO994083 A NO 994083A NO 994083 A NO994083 A NO 994083A NO 994083 D0 NO994083 D0 NO 994083D0
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- pharmaceutical compounds
- epoxidation method
- selective epoxidation
- selective
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D303/40—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D303/46—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by amide or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3911497P | 1997-02-26 | 1997-02-26 | |
US3911697P | 1997-02-26 | 1997-02-26 | |
PCT/US1998/003667 WO1998038164A1 (en) | 1997-02-26 | 1998-02-25 | Selective epoxidation process for preparing pharmaceutical compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
NO994083D0 true NO994083D0 (no) | 1999-08-24 |
NO994083L NO994083L (no) | 1999-10-25 |
Family
ID=26715826
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO994049A NO994049L (no) | 1997-02-26 | 1999-08-23 | Metode for aa fremstille farmasöytiske forbindelser |
NO994083A NO994083L (no) | 1997-02-26 | 1999-08-24 | Selektiv epoksideringsmetode for fremstilling av farmasöytiske forbindelser |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO994049A NO994049L (no) | 1997-02-26 | 1999-08-23 | Metode for aa fremstille farmasöytiske forbindelser |
Country Status (17)
Country | Link |
---|---|
US (1) | US6143909A (no) |
EP (2) | EP0861839A1 (no) |
JP (2) | JP2002513403A (no) |
KR (2) | KR20000075623A (no) |
CN (2) | CN1252788A (no) |
AU (2) | AU6667198A (no) |
BR (2) | BR9811252A (no) |
CA (2) | CA2281108A1 (no) |
CZ (1) | CZ9902998A3 (no) |
EA (2) | EA199900770A1 (no) |
ID (2) | ID22984A (no) |
IL (2) | IL131205A0 (no) |
NO (2) | NO994049L (no) |
NZ (1) | NZ336918A (no) |
PL (2) | PL335478A1 (no) |
TR (2) | TR199902065T2 (no) |
WO (2) | WO1998038164A1 (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5977387A (en) * | 1996-08-30 | 1999-11-02 | Eli Lilly And Company | Process for preparing pharmaceutical compounds |
CA2264557A1 (en) * | 1996-09-06 | 1998-03-12 | Eli Lilly And Company | Process and novel intermediates |
KR20010099699A (ko) * | 1998-10-16 | 2001-11-09 | 웨인 스테이트 유니버시티 | 크립토피신의 입체선택적 제조 방법 |
WO2000034253A2 (en) * | 1998-12-07 | 2000-06-15 | Eli Lilly And Company | Intermediates and reaction sequence to produce said intermediates useful for the preparation of antineoplastic and antifungal cryptophycin derivatives |
WO2000034252A2 (en) * | 1998-12-07 | 2000-06-15 | Eli Lilly And Company | Process for the preparation of cryptophycin derivatives |
WO2001024763A2 (en) | 1999-10-01 | 2001-04-12 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
EP1751279A4 (en) * | 2004-05-05 | 2008-03-19 | Univ Minnesota | NUCLEIC ACIDS AND POLYPEPTIDES INVOLVED IN THE PREPARATION OF CRYPTOPHYCIN |
CN101962323B (zh) * | 2010-07-16 | 2013-06-05 | 中国人民解放军第二军医大学 | 2-丙烯酰x基-3-取代苯基丙酸类化合物及其用途 |
CN111333560B (zh) * | 2020-04-13 | 2024-01-23 | 合肥工业大学 | 一种制备螺环β-内酰胺的方法 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4946835A (en) * | 1988-07-15 | 1990-08-07 | Merck & Co., Inc. | Antifungal fermentation product and method |
US4868208A (en) * | 1988-07-15 | 1989-09-19 | Merck & Co., Inc. | Antifungal agent and method |
US4845086A (en) * | 1988-08-09 | 1989-07-04 | Merck & Co., Inc. | Antifungal agent |
US4845085A (en) * | 1988-08-09 | 1989-07-04 | Merck & Co., Inc. | Antifungal agent |
NZ232562A (en) * | 1989-02-17 | 1992-10-28 | Coselco Mimotopes Pty Ltd | Immobilised peptide - solid support comprising a cleavable ester link between the peptide carboxy terminus and the solid support |
US5256802A (en) * | 1990-04-03 | 1993-10-26 | Miles Inc. | Process for the production of oxiranes |
NZ257077A (en) * | 1992-11-06 | 1997-05-26 | Chiron Mimotopes Pty Ltd | Support for synthesis of modular polymers |
GB2282384B8 (en) * | 1993-08-18 | 1997-09-04 | Europ Economic Community | Drug delivery agents incorporating mitomycin |
US5952298A (en) * | 1993-12-21 | 1999-09-14 | The University Of Hawaii | Cryptophycins |
CA2179490A1 (en) * | 1993-12-21 | 1995-06-29 | Trimurtulu Golakoti | New cryptophycins |
DE69516415T2 (de) * | 1994-10-14 | 2000-09-14 | Stratagene La Jolla | Porphyrin-markierung von polynukleotiden |
DE69633667T2 (de) * | 1995-03-07 | 2006-03-02 | University Of Hawaii, Honolulu | Neue synthetische cryptophycine |
AU716620B2 (en) * | 1995-03-31 | 2000-03-02 | Nippon Chemiphar Co. Ltd. | Epoxysuccinic acid derivatives |
US5700826A (en) * | 1995-06-07 | 1997-12-23 | Ontogen Corporation | 1,2,4,5-tetra substituted imidazoles as modulators of multi-drug resistance |
CA2230540A1 (en) * | 1995-08-30 | 1997-03-06 | Eli Lilly And Company | Pharmaceutical compounds |
AU1469097A (en) * | 1995-12-22 | 1997-07-17 | Eli Lilly And Company | Pharmaceutical compounds |
US5843865A (en) * | 1996-02-07 | 1998-12-01 | Buckman Laboratories International, Inc. | Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using the same |
ES2156338T3 (es) * | 1996-02-27 | 2001-06-16 | Lilly Co Eli | Derivados de criptoficina y su uso como agentes antimicrotubulos. |
CA2264297A1 (en) * | 1996-08-30 | 1998-03-05 | Chuan Shih | Pharmaceutical compounds |
AU4330097A (en) * | 1996-08-30 | 1998-03-19 | Eli Lilly And Company | Pharmaceutical compounds |
CN100356916C (zh) * | 1996-08-30 | 2007-12-26 | 夏威夷大学 | 药物化合物 |
US6025506A (en) * | 1997-02-21 | 2000-02-15 | Dsm N.V. | Process for preparing an optically active phenylglycidyl acid derivative |
TW438787B (en) * | 1997-02-27 | 2001-06-07 | Tanabe Seiyaku Co | Process for preparing optically active trans-3-substituted glycidic acid ester |
-
1998
- 1998-02-25 CN CN98804250A patent/CN1252788A/zh active Pending
- 1998-02-25 IL IL13120598A patent/IL131205A0/xx unknown
- 1998-02-25 BR BR9811252-0A patent/BR9811252A/pt not_active IP Right Cessation
- 1998-02-25 EA EA199900770A patent/EA199900770A1/ru unknown
- 1998-02-25 PL PL98335478A patent/PL335478A1/xx unknown
- 1998-02-25 CZ CZ19992998A patent/CZ9902998A3/cs unknown
- 1998-02-25 BR BR9807265-0A patent/BR9807265A/pt unknown
- 1998-02-25 KR KR1019997007686A patent/KR20000075623A/ko not_active Application Discontinuation
- 1998-02-25 TR TR1999/02065T patent/TR199902065T2/xx unknown
- 1998-02-25 EP EP98301368A patent/EP0861839A1/en not_active Ceased
- 1998-02-25 AU AU66671/98A patent/AU6667198A/en not_active Abandoned
- 1998-02-25 EA EA199900772A patent/EA002547B1/ru not_active IP Right Cessation
- 1998-02-25 PL PL98335347A patent/PL335347A1/xx unknown
- 1998-02-25 EP EP98301367A patent/EP0861838A3/en not_active Withdrawn
- 1998-02-25 TR TR1999/02064T patent/TR199902064T2/xx unknown
- 1998-02-25 CA CA002281108A patent/CA2281108A1/en not_active Abandoned
- 1998-02-25 WO PCT/US1998/003667 patent/WO1998038164A1/en not_active Application Discontinuation
- 1998-02-25 IL IL13116298A patent/IL131162A0/xx unknown
- 1998-02-25 ID IDW990901A patent/ID22984A/id unknown
- 1998-02-25 CA CA002281104A patent/CA2281104A1/en not_active Abandoned
- 1998-02-25 WO PCT/US1998/003655 patent/WO1998038158A1/en active Search and Examination
- 1998-02-25 AU AU66672/98A patent/AU738999B2/en not_active Ceased
- 1998-02-25 JP JP53780398A patent/JP2002513403A/ja active Pending
- 1998-02-25 CN CN98804251A patent/CN1255121A/zh active Pending
- 1998-02-25 JP JP53779998A patent/JP2002512603A/ja active Pending
- 1998-02-25 KR KR1019997007737A patent/KR20000075671A/ko not_active Application Discontinuation
- 1998-02-25 ID IDW990900D patent/ID24527A/id unknown
- 1998-02-25 US US09/380,005 patent/US6143909A/en not_active Expired - Fee Related
- 1998-02-25 NZ NZ336918A patent/NZ336918A/en unknown
-
1999
- 1999-08-23 NO NO994049A patent/NO994049L/no not_active Application Discontinuation
- 1999-08-24 NO NO994083A patent/NO994083L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20002443L (no) | FremgangsmÕte for fremstilling av derivater av taxoidklassen | |
PT892640E (pt) | Composicoes farmaceuticas de micofenolato entericamente revestidas | |
NO20001728D0 (no) | Fremgangsmåte for fremstilling av chirale forbindelser | |
NO20000189L (no) | Fremgangsmõte for fremstilling av heparin | |
NO20002174L (no) | FremgangsmÕte for fremstilling av tiazolidindion-derivater | |
NO994083D0 (no) | Selektiv epoksideringsmetode for fremstilling av farmasöytiske forbindelser | |
NO20024059D0 (no) | Fremgangsmåte for fremstilling av et oksazolyletanolderivat | |
NO20023937D0 (no) | Fremgangsmåte for fremstilling av substituert tiazolidindion | |
TR199800403A3 (tr) | a-Bromo-laktam türevlerinin hazirlanmasi için yöntem. | |
NO993912D0 (no) | Fremgangsmåte for fremstilling av eprosartan | |
NO993913L (no) | FremgangsmÕte for fremstilling av eprosartan | |
NO996432L (no) | Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider | |
DK0871616T3 (da) | Fremgangsmåde til fremstilling af lægemidler mod malaria | |
NO304110B1 (no) | FremgangsmÕte for fremstilling av glutardialdehyd | |
EE200000401A (et) | Farmatseutilise preparaadi valmistamismeetod | |
NO995750D0 (no) | Fremgangsmåte til fremstilling av et deoksyuridinderivat | |
NO20003077D0 (no) | FremgangsmÕte for fremstilling av klorbenzooksazolen | |
NO991679L (no) | Fremgangsmaate for fremstilling av fenoksyfenylsulfonylhalider | |
NO20013044D0 (no) | Fremgangsmåte for fremstilling av NG-substituerte deaza- adenosinderivater | |
NO20012811D0 (no) | Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat | |
NO994557D0 (no) | Fremgangsmaate for fremstilling av arylaminotriazolopyridiner | |
NO20020328D0 (no) | Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol | |
NO982975L (no) | FremgangsmÕte for fremstilling av fosfatbundne keramer | |
NO20002476L (no) | FremgangsmÕte for fremstilling av formylimidazoler | |
NO20020327D0 (no) | Fremgangsmåte for fremstilling av 2-aminometyl-4-cyano-tiazol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |